Laser vision correction procedure volume by LCA-Vision Inc. in Cincinnati continued to declined in the fourth quarter of 2009, the company reported Tuesday.
The Ohio Third Frontier program has attracted $3.2 billion in private investment since it began seven years ago, according to a recent report by the Ohio Business Roundtable. The Roundtable is one of the leading proponents of renewing Ohio Third Frontier through a May 2010 ballot initiative.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Kendle International Inc. on Tuesday announced an executive realignment as the latest in a series of efforts to better position the company as a top-tier, global contract research organization. Kendle has appointed its co-founder and chief operating officer, Christopher C. Bergen, to the new position of chief administrative officer as one of the changes to drive innovation and efficiency at the company.
Innovation in medical devices. Innovation in vaccines. Even innovation in regulating drug development -- MedCity News saw it all last week.
Kendle stated that its new operations in Kuala Lumpur, Manila and Bagnkok will expand its competitive edge in the region. Kendle, based in Cincinnati, has operated in Asia since 1998 and already has a total of eight offices in China, India, Singapore and Australia.